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Objective: The interaction between thyroid status and brown adipose tissue (BAT) activation is
complex. We assessed the effect of autoimmune hypothyroidism (ATD) in female children on BAT
activation, measured using infrared thermography.
Design: Twenty-six female participants (14 with ATD and 12 healthy controls) between 5 and 17 years
of age attended a single study session. Thermal images were taken of the supraclavicular region before,
and after, the introduction of a cool stimulus.
Results:Participants with ATDhad lower resting (hypothyroid, 34.96 0.7°C; control, 35.46 0.5°C;P5
0.03) and stimulated (hypothyroid, 35.0 6 0.6°C; control, 35.5 6 0.5°C; P 5 0.04) supraclavicular
temperatures compared with controls, but there was no difference between groups in the temperature
increase with stimulation. BAT activation, calculated as the relative temperature change comparing the
supraclavicular temperature to a sternal reference region, was reduced in participants with ATD
(hypothyroid, 0.1 6 0.1°C; control, 0.2 6 0.2°C; P 5 0.04). Children with ATD were frequently bio-
chemically euthyroid due to replacement therapy, but, despite this, increased relative supraclavicular
temperature was closely associated with increased TSH (r 5 0.7, P 5 0.01) concentrations.
Conclusions: Girls with ATD had an attenuated thermogenic response to cold stimulation compared
with healthy controls, but, contrary to expectation, those with suboptimal biochemical control (with
higher TSH) showed increased BAT activation. This suggests that the underlying disease process may
have a negative effect on BAT response, but high levels of TSH can mitigate, and even stimulate, BAT
activity. In summary, thyroid status is a complex determinant of BAT activity in girls with ATD.
Copyright © 2019 Endocrine Society
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Since its rediscovery in adult humans in 2009 [1–4], interest in brown adipose tissue (BAT)
has increased steadily. BAT has an integral role in adaptive thermogenesis due to its capacity
to rapidly generate significant quantities of heat from fatty acids and glucose, facilitated by
uncoupling protein 1 (UCP1) in the mitochondrial membrane, allowing the disassociation of
ATP production from mitochondrial respiration [5–9]. As heat is eventually lost from the
body, this represents a net loss of energy and has the potential to contribute to body weight
management. Despite promising results in rodents demonstrating weight loss, improved
metabolic profiles, and greater insulin sensitivity following BAT stimulation [10–15],
translation to human studies has been slow [16]. Human studies have been limited by high
ionizing radiation associated with positron emission tomography (PET)–CT, considered to be
the gold standard for imaging BAT. Thermal imaging has been established as a valid
alternative [17–20].
As a major regulator of energy expenditure, the thyroid axis can modulate the heat-
generating capability of BAT [21, 22]. Thyroid hormones cross the blood–brain barrier [23]
and act on the hypothalamus to increase sympathetic nervous system (SNS) activation [24].
Under SNS control, brown adipocytes express elevated iodothyronine deiodinase 2, which
converts intracytoplasmic free T4, taken up from the systemic circulation, into its meta-
bolically active form, T3 [25, 26], causing a localized intracellular hyperthyroid environment.
Translocation and binding of T3 to its intranuclear thyroid hormone receptor-b stimulates
UCP1 transcription and translation [27], leading to heat generation. Reduced thyroid hor-
mone concentrations may, therefore, affect BAT activity directly or by reducing SNS acti-
vation centrally. Despite this defined mechanistic pathway, in vivo studies in humans are
limited and conflicting. In healthy volunteers, BAT activation is not associated with serum
thyroid hormone concentrations [28, 29] but is with higher TSH concentrations [29]. BAT
activity is increased in patients with hyperthyroidism and returns to normal after treatment
[30]. In patients with hypothyroidism, BAT remains present, and indeed may become
markedly hypertrophic in the absence of replacement therapy [31]. However, it is not clear
whether treatment with T4 increases [32] or decreases [33] BAT activity, although a recent
small study in healthy adults demonstrated a negative correlation between plasma free T4
and BAT volume [34].
Thyroid hormones are essential for brain and physical development in early life [35, 36]
and continue to be critical through childhood when BAT activity is also increased [37, 38].
Adiposity patterns developed in this period can predict later obesity and metabolic health
[39–43]. The influence of thyroid hormones on BAT activity, however, has not been examined
in otherwise healthy children. Despite many patients achieving biochemical euthyroidaemia,
physiological diurnal variation in TSH and thyroid hormone profiles is not achieved with
hormone replacement therapy [44, 45].
Pediatric patients with hypothyroidism, for the most part, either have congenital hypo-
thyroidism or autoimmune hypothyroidism, with the latter being more common in girls than
boys. BAT is known to vary between sexes [46, 47], and so, to reduce heterogeneity, we
compared girls with a diagnosis of autoimmune hypothyroidism (ATD) who, we hypothesized,
would show reduced BAT activation in response to a cool stimulus compared with healthy age
and sex-matched controls. We further hypothesized that those in the hypothyroid group who
were relatively biochemically hypothyroid would have lower BAT activation than those who
were relatively biochemically hyperthyroid.
1. Materials and Methods
A. Participants
To determine the effect of ATD on the response of BAT to a cool stimulus, female children and
adolescents (5 to 17 years of age) with a diagnosis of ATD [defined as a TSH level .10 mU/L
and anti–thyroid peroxidase (TPO) antibodies levels of .60 IU/L at diagnosis] and no
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associated major disease (n 5 14) were compared with healthy, age-matched controls (n 5
12). All participants successfully completed the study protocol.
Participants with ATD were recruited from the pediatric endocrinology clinic of Not-
tinghamUniversity Hospital NHS Trust (Nottingham, UK). Control participants were either
healthy siblings of participants with ATD or were attending the pediatric ear, nose, and
throat clinic at the Nottingham University Hospitals NHS Trust for unrelated simple
surgical procedures (such as grommet insertion or tonsillectomy). The study was approved by
the Nottingham-2 NHS Research Ethics Committee (13/EM/0102) and performed in ac-
cordance with the Declaration of Helsinki. Written, informed consent was provided prior to
participation from the child or her parent or legal guardian as appropriate. If consent was
provided by the parent or legal guardian, the child was invited to provide written assent.
B. Study Sessions
Participants attended a 1-hour study session undertaken in the Academic Child Health
Human Physiology laboratory in the Queen’s Medical Centre campus of the University of
Nottingham. Following informed consent, participants were required to wear a standard
light cotton vest (0.06 Clo). A targetedmedical history, currentmedications, and details of the
last meal and physical activity during the preceding 24 hours were obtained from the child or
her parent or caregiver. Basic anthropometricmeasurements of height andweight weremade
using a stadiometer (Seca, Hamburg, Germany) and class III digital weighing scales (Seca
899, Seca), respectively. The child or young person then sat upright, directly opposite a
thermal imaging camera (FLIR B425, FLIR Systems, Danderyd, Sweden), which was level
with her larynx [48] at a distance of;1 m to ensure the shoulders remained within the frame
while optimizing the proportion of the frame occupied by the region of interest (ROI). Skin
temperature probes (M1024254, GE Healthcare, Fairfield, CT) were attached to the dorsum
of the left hand and 2 cm below themidpoint of the left clavicle. Heart rate was recorded using
pulse oximetry (Radical 7 pulse oximeter, Massimo, Irvine, CA) connected to the index finger
of the left hand. The right hand was placed in an empty 5-L receptacle. Following an ac-
climatization period of at least 20 minutes, baseline images were acquired every 20 seconds
for 1 minute followed by the introduction of cool water [median, 18.5°C; interquartile range
(IQR), 18.0° to 18.9°C] into the receptacle to cover the right hand of the participant to the level
of the distal forearm. A further 5 minutes of images were acquired at the same rate of three
per minute. Children were free to stop at any time, but there were no reports of discomfort
during the study imaging protocol and all sessions were completed.
C. Image Analysis
Thermal images saved in FLIR’s proprietary JPEG format were converted to an openly
accessible 16-bit portable network graphics format [18] and the radiometric data were
converted to temperature data within MATLAB (2017b, Mathworks, Natick, MA) using a
script adapted from Tattersall [49], producing temperature data identical to those produced
by FLIR software (ThermaCAM Researcher Pro 2.10; data not shown).
Data were analyzed within the MATLAB programming environment, as previously de-
scribed [18]. In brief, the image was displayed on a graphical user interface allowing the user
to identify five points representing the apices of the supraclavicular ROIs [18, 50]. The outline
of the ROI was then calculated as (i) straight lines from the neck and shoulder apices to the
central apex and (ii) the shoulder contour between the shoulder and neck apices. This method
allowed the accurate, efficient, and reproducible identification of the ROIs (data not shown).
Temperature points within the ROIs were then analyzed to identify the hottest 10%, cor-
responding to BAT [18]. The supraclavicular temperature (TSCV) was defined as the median
temperature of the hotspot (equivalent to the 95th percentile of the ROI). Additionally, the
median temperature of a circular reference region on the sternum, directly inferior to the
central apex, with a diameter of 10 pixels was calculated.
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D. Hormone Analysis
Plasma thyroid hormones and TSH were measured using Siemens ADVIA Centaur im-
munoassay systems with the following kits: FT3 assay no. 03154228 (119781) (reference
ranges: 2 to 12 years, 5.1 to 7.4 pmol/L; 13 to 20 years, 4.7 to 7.2 pmol/L; intra-assay coefficient
2.6%), FT4 assay no. 06490106 (reference ranges: 2 to 12 years, 11.1 to 18.1 pmol/L; 13 to 20
years, 10.7 to 18.4 pmol/L; interassay coefficient 2.9%; intra-assay coefficient 2.7%), and
TSH3-Ultra assay no. 06491080 (reference ranges: 2 to 12 years, 0.67 to 4.16 mU/L; 13 to 20
years, 0.48 to 4.17 mU/L; interassay coefficient 2.5%, intra-assay coefficient 2.3%). Anti-TPO
antibodies were measured with the kit no. 10630887 (interassay coefficient 3.1%, intra-assay
coefficient 4.1%).
E. Dietary and Physical Activity Analysis
Nutritional data were analyzed for nutrient composition (energy, carbohydrate, fat, and
protein content) using online nutritional software (Cronometer, Revelstoke, BC, Canada;
https://cronometer.com/).
Participants were asked to rate their involvement in a number of activities in three recent
time periods (before school, during school, and after school) as either “None,” “A little,” or “A
lot” using a standardized questionnaire [51]. Activities were classified as physical (such as
running) or sedentary (such as watching television), and the number of activities in each
category was summed.
F. Statistical Analysis
Anthropometric data [height, weight, and body mass index (BMI)] were analyzed both as
absolute values and as age- and sex-normalized SD scores (SDSs). TSH results were natural
log transformed (lnTSH) for further analysis to reduce data skew (Fig. 1A and 1B).
The relative supraclavicular temperature (TRel) was calculated by the difference between
the supraclavicular and reference-region temperature (TRel 5 TSCV 2 TRef). Resting tem-
peratures were defined as the mean of the images in the minute prior to the introduction of
the cool stimulus. A rolling average of 1-minute duration was calculated for the stimulation
period, and the stimulated temperatures were defined as the maximum rolling average
temperature during stimulation. Change in temperature (DT) was the difference between
resting and stimulated temperatures. Summary measures are presented as the mean of each
group with the difference and 95% CI of the difference unless otherwise stated. Independent
Student t tests were used to compare BAT activation, as the change in relative temperature in
response to the cool stimulus (DTRel), between the groups. Percentages were compared
using a x2 test. Adjusted P values were calculated using linear regression. Statistical analysis
was carried out using R: A Language and Environment for Statistical Computing, version
3.4.3 (R Core Team).
2. Results
There was no significant difference between participants in the ATD group and the control
group in terms of baseline characteristics, although there was a trend toward participants in
the ATD group being shorter for their age, as previously reported [52], and having a higher
BMI (Table 1). Four (29%) of the participants were newly diagnosed (,1 month) and/or had
not yet started treatment, and 10 (71%) had an existing diagnosis. Themedian (IQR) length of
diagnosis was 61.5 (4.4 to 133) weeks and the age at diagnosis was 12 (11.2 to 13.8) years,
which reflects the typical age of onset of ATD [53]. All children in the study groupwere treated
with, or due to start, levothyroxine [median (IQR) dose: 50 (50 to 100)mg, 1.3 (0.7 to 1.7)mg/kg],
andmost children did not have significantly abnormal TSH, free T3, or free T4 on the day of
testing (Fig. 1C). The median (IQR) TSH was 4.1 mU/L (3.5 to 15.7; normal range, 0.3 to
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5.5), free T4 was 15.9 pmol/L (11.2 to 17.5; normal range, 10.0 to 19.8), and free T3 was 5.6
pmol/L (5.0 to 5.8; normal range, 3.5 to 6.7). Anti-TPO antibodies were raised in all patients
at diagnosis (.1300 IU/mL in nine participants, 90.2 to 273.7 IU/mL in the other
five participants).
There was no difference in the study conditions between the groups, including stimulation
temperature, outside temperature, room temperature, time since the last meal, or in the
number of physical activity sessions or sedentary sessions (Table 2). Energy and carbohydrate
Figure 1. (A) TSH concentrations in participants with ATD. (B) Natural lnTSH
concentrations in participants with ATD. 3, low; s, normal; C, borderline high; 4, high;
:, very high. (C) Venn diagram results of thyroid function tests of ATD group participants.
In two cases where only a TSH was available (both in the normal range), the T3 and T4 were
presumed to be normal; in three further cases where only a T3 result was not available, the
T3 was presumed to be in the same category as the T4 result (one normal with a normal T4
and TSH, one normal with a normal T4 and high TSH, *one low with a low T4 and very high
TSH); and two cases with borderline TSH concentration (5.6 to 10.0 mU/L) were classified as
normal as both T3 and T4 levels were normal.
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content of the last meal was higher in the control group, but this did not reach statistical
significance. Protein content was similar but fat content trended toward being significantly
higher in the control group (P, 0.1; Table 2). Heart rate was similar between the groups and
did not change significantly following stimulation (Table 3).
Absolute TSCV was lower in participants with ATD than in control participants in both the
resting and stimulated state. There was less separation between the groups in resting and
stimulated TRel than TSCV and the difference was not significant. Age, BMI andBMI SDS, and
weight and weight SDS were negatively associated with TSCV, but not TRel, DTSCV, or DTRel,
and they were closely correlated with each other (Fig. 2). Neither height nor height SDS was
associated with TSCV or TRel. Because BMI SDS correlated with TSCV, trended toward being
significantly different between the groups, and there is a known relationship between BMI
and BAT activity [4, 54–57], a P value adjusted for BMI SDS was calculated using linear
regression (Table 4).
The mean response to cold water stimulation (mean DTSCV) was 0.15°C (95% CI, 0.12° to
0.18°; P , 0.001). DTSCV was similar between groups, but the relative response to cold water
stimulation (DTRel) was significantly reduced in participants with ATD compared with
healthy controls (Table 4). Although the ATD group also had a lower resting and stimulated
TSCV, after controlling for BMI SDS, the difference was no longer statistically significant
(resting TSCV, F2,23 5 6.5, P 5 0.10; stimulated TSCV, F2,23 5 7.1, P 5 0.12). There was no
difference in the resting or stimulated TRel between the groups, but there was a significant
positive correlation in the ATD group with lnTSH (Fig. 3; resting TRel, r 5 0.7, P 5 0.009;
stimulated TRel, r 5 0.7, P 5 0.01) and negative correlation with T4 (resting TRel, r 5 20.6,
P 5 0.04; stimulated TRel, r 5 20.6, P 5 0.04), with a similar pattern seen at all time points
Table 1. Characteristics of Participants
ATD Control Difference (95% CI) P
n 14 12
Age, y 13.20 11.48 21.72 (23.88 to 0.44) 0.11
Height, cm 152.1 150.6 21.4 (214.8 to 12.0) 0.83
Height SDS 20.33 0.71 1.03 (20.01 to 2.08) 0.05
Weight, kg 55.5 47.2 28.3 (221.4 to 4.8) 0.20
Weight SDS 0.94 0.83 20.11 (21.09 to 0.86) 0.82
BMI, kg/m2 23.7 20.0 23.6 (27.3 to 0.0) 0.05
BMI SDS 1.26 0.65 20.61 (21.54 to 0.33) 0.19
Core temperature, °C 36.8 36.8 0 (20.4 to 0.4) 0.98
P values are results of t tests.
Table 2. Study Conditions of Each Group
ATD Control Difference (95% CI) P
Room temperature, °C 24.5 24.5 20.0 (21.3 to 1.2) 0.98
Outdoor temperature, °C 15.2 15.7 0.5 (22.2 to 3.2) 0.71
Water (stimulus) temperature, °C 18.3 18.5 0.2 (20.5 to 0.9) 0.56
Time since last meal, h 5.5 4.4 21.2 (26.1 to 3.7) 0.63
Energy of last meal, kcal 304 401 97 (241 to 236) 0.16
Carbohydrate content of last meal, g 41 52 11 (27 to 29) 0.22
Fat content of last meal, g 9 14 6 0.06a
Protein content of last meal, g 9 11 1 0.62a
Number of physical activities 10.4 10.8 0.5 (24 to 4.9) 0.83
Number of sedentary activities 5.4 5.7 0.3 (21.7 to 2.3) 0.75
Values are means, and P values are the results of t tests (except as noted).
aValue is the median, and P value is the result of a Mann–Whitney test.
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(data not shown). In the nine participants for whom data were available, there was no
correlation between T3 and resting, stimulated, or change in TSCV.
To further define the relationship between thyroid function and TRel, participants with
ATD were categorized as either biochemically hypothyroid or biochemically euthyroid/
hyperthyroid. A TSH cutoff of .10 mU/L was used to define the biochemically hypothy-
roid group. Compared with girls who were biochemically euthyroid or hyperthyroid (n5 10),
biochemically hypothyroid girls (n 5 4) had a significantly greater resting TRel [high TSH
group, 1.7°C; low TSH group, 2.5°C; difference, 0.8°C (95% CI, 21.6° to 0.0°); P 5 0.04; Fig.
3C] and a trend toward a greater stimulated TRel [high TSH group, 2.6°C; low TSH group,
1.8°C, difference 0.8°C (95% CI, 0.0° to 1.5°), P 5 0.05]. There was no difference in change in
temperature (DTRel) or in TSCV.
Post hoc analysis did not show any meaningful association between TSCV or TRel and
sedentary behavior, physical activity, or nutritional composition of the last meal (energy,
carbohydrate, fat, and protein content), once removal of a single influential outlier in sed-
entary behavior was excluded and fat content was corrected for BMI SDS. Increased car-
bohydrate content in the preceding meal was associated with lower DTRel, but visual
inspection of the results failed to indicate a valid relationship.
3. Discussion
We demonstrate that female children and adolescents with ATD have a reduced thermogenic
response to cold stimulation, as measured by the change in relative supraclavicular tem-
perature (DTRel), which has been shown to be closely correlated with BAT activity measured
using fludeoxyglucose (18F) PET-CT [17–20]. However, contrary to expectation, those chil-
dren with ATD who were currently biochemically hypothyroid (defined as TSH .10 mU/L)
demonstrated greater resting and stimulated TRel than did their biochemically euthyroid
counterparts, and a strong positive correlation was seen between TSH and BAT thermo-
genesis in the ATD group, indicated by resting and stimulated TRel. These apparently
contradictory findings may help to explain the contrary and conflicting information pre-
viously published on this subject [28–30, 32–34]. Unfortunately, plasma TSH and thyroid
hormone levels were not available for the control group, as this would have helped delineate
further between the effect of the underlying disease and the effect of the TSH per se. However,
in the subset of the groupwith ATDwho did not have raised TSH, the relative supraclavicular
temperature closely mirrors the distribution seen in a healthy population, indicating that the
raised TRel is a consequence of the biochemical pathology, rather than the underlying au-
toimmune process, and that, given appropriate replacement therapy, this difference can be
moderated. That the change in TRel in response to cold stimulation remains different between
the study group and healthy controls suggests that a subtler difference in the thermogenic
response of BAT remains, potentially independent of thyroid hormone levels.
BAT has been shown to interact with immunomodulation, potentially helping to identify
self and prevent autoimmunity developing. Adipectomy of the intrascapular BAT in rats
increases autoimmune processes [58, 59] and, in humans, lipodystrophy is associated
with autoimmune diseases [60, 61]. This raises the possibility that the reduced BAT
Table 3. Summary of Heart Rate by Group Before, and During, Cold Stimulation
ATD Control Difference (95% CI) P
Resting HR, bpm 77 83 7 (22 to 15) 0.11
Stimulated HR, bpm 79 87 8 (22 to 17) 0.13
Difference, bpm (95% CI) 2 (212 to 7) 3 (212 to 5)
P 0.62 0.41
P values are results of t tests.
Abbreviations: bpm, beats per minute; HR, heart rate.
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thermogenesis seen is, in fact, due to reduced BAT activity predisposing to autoimmune
disease, rather than being a consequence of it, and that those with autoimmune disease may
have less BAT prior to the onset of the later autoimmune pathology. However, there is no
direct evidence for this in humans, and the animal models of near-total adipectomy
represent a much greater insult than the difference that might be expected to occur between
individuals naturally. The effects, if present, would therefore probably be subtle and likely to
require larger studies to be detected.
Alternatively, theremay be an autoimmune process reducing BAT thermogenesis directly.
Anti-TPO antibodies have little cross-reactivity outside of the thyroid gland, except for breast
tissue [62, 63] and possibly myeloperoxidase [64], so it is unlikely that they directly affect
Figure 2. Correlogram of association between participant characteristics (age, BMI and BMI
SDS, height and height SDS, and weight and weight SDS) and thermographic BAT
measurements [resting, stimulated, and change (D) in TSCV and resting, stimulated, and
change in TRel]. Only significant (P , 0.05) associations are shown. Ellipse size and shading
indicate the absolute value of the Pearson correlation coefficient (r 5 0, white; |r| 5 1, black);
ellipse direction indicates the sign of the coefficient [down (\), negative; up (/), positive].
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BAT. However, the presence of one autoimmune antibody increases the likelihood of the
presence of another [65–69]. As only anti-TPO antibodies were measured in the study group,
whether anti–TSH receptor antibodies or other antibodies were present is not known, and
future research may want to consider testing a wider panel of autoantibodies to explore
this further.
An alternative explanation may lie in the lack of physiological diurnal variation in thyroid
hormones observed in patients on mono T4 replacement therapy. In the absence of thyroid
disease, TSH levels are lower in the day, with a nadir in the late afternoon (between 3:00 and
5:00 PM) and 140% higher at night, peaking at 11:00 PM in children (and 2:00 to 4:00 AM in
adults), along with a shorter 30-minute pulsatile cycle overlying the diurnal rhythm [44, 45].
There is a mirroring, but subtler, rise in both T4 and T3 levels, which increase;7% and 15%,
respectively, thought to be in response to TSH pulses, but also a rise in the morning in-
dependent of TSH, resulting in the highest levels in the morning and lowest in the late
afternoon, along with a similar overlying short pulsatile cycle [44, 45]. Replacement therapy
is typically (and for all participants in the study group) with levothyroxine (T4), taken once a
day and usually in the morning. On replacement therapy, the TSH variation remains but the
T3 and T4 levels rise to a maximum 3 hours after ingestion, in the middle of the day, before
falling until the following dose the next morning [70], and there is no short pulsatile cycle
overlying the diurnal cycle. BAT is known to exhibit a circadian rhythm [20] and, given the
critical role of thyroid hormones in the cellular biochemistry of the brown adipocyte, the
diurnal thyroid hormone variation may be important to the proper function of BAT and its
absence may diminish the ability of BAT to respond maximally to a cold challenge. Ad-
ditionally, levothyroxine monotherapy does not always fully resolve symptoms of hypothy-
roidism, and quality of life scores remain below those of healthy controls [71, 72], possibly due to
a lack of euthyroid status at the tissue level [73–75]. A TSH in the normal range may be
insufficient to drive the local conversion toT3within the brown adipocyte,where T3 is not being
produced by the thyroid gland (normally thought to account for 20% of circulating levels [76]).
The TSH receptor, previously thought only to be expressed by thyroid follicular cells, has
now been shown to be expressed on many other extrathyroidal cells, including BAT [77–79],
at least in small mammals. Furthermore, the insertion of an activating TSH receptor mu-
tation to human orbital preadipocytes increases UCP1 gene expression [80]. Our results
suggest a similar potential mechanism for activation of classical BAT depots in vivo in
humans, but an indirect mechanism, either due to increased sensitivity to cold or by changes
in plasma T3 and T4, should also be considered. Additionally, changes in thyroid hormone
concentrations may affect BAT directly or via a central effect on the SNS, and the response to
thyroid replacement therapy can vary between tissues [81], raising the possibility that the
tissue-level thyroid status was not fully reflected by serum TSH concentrations, despite the
buffering action of deiodinases.
Even in the presence of frank biochemical hypothyroidism, our results would suggest that
TSH is able to exert a marked thermogenic influence on BAT, either directly or indirectly,
raising the resting activity level while still allowing a similar response to the cold challenge,
Table 4. Absolute and Relative Supraclavicular BAT Temperatures (°C) of Each Group
ATD Control
Difference
(95% CI) P
Difference
(Adjusted) P (Adjusted)
Resting TSCV 34.9 35.4 0.5 (0.1 to 1.0) 0.03 0.4 0.10
Resting TRel 1.9 1.6 20.4 (20.9 to 0.2) 0.20 20.3 0.27
Stimulated TSCV 35.0 35.5 0.5 (0.0 to 0.9) 0.04 0.3 0.13
Stimulated TRel 2.1 1.8 20.3 (20.8 to 0.3) 0.33 20.2 0.42
DTSCV 0.2 0.1 20.0 (20.1 to 0.0) 0.29 20.1 0.20
DTRel 0.1 0.2 0.1 (0.0 to 0.2) 0.04 0.1 0.03
P values are results of t tests. Adjusted values are the result of a linear model adjusting for BMI SDS.
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Figure 3. Association between lnTSH concentration of participants in the ATD group and
(A) resting TRel (r 5 0.7, P 5 0.01) and (B) stimulated TRel (r 5 0.7, P 5 0.01). (C) Resting
TRel of girls in the control group (4) compared with those with ATD who were biochemically
euthyroid/hyperthyroid (TSH #10 mU/L, C) and those who were biochemically hypothyroid
(TSH .10 mU/L, s). Bars are mean 6 SEM.
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even in the near absence of thyroid hormones. Via upregulation of iodothyronine deiodinase
2, the relatively abundant T4 can be converted intracellularly to the biologically active T3,
potentially maintaining intracellular concentrations. This points to the critical importance of
the BAT for survival.
Clearly, the relationship between thyroid status and BAT activity is complex, but the close
association between TSH with both resting and stimulated relative BAT temperatures
further adds to the concept that thyroid status is an important determinant of BAT activity in
humans [22].
To further elucidate this, future studies should consider longitudinal repeat imaging
of participants with a new diagnosis of hypothyroidism to assess the changes in BAT
activity as they return a biochemical euthyroid status following initiation of thyroid
replacement therapy.
Although the age difference was not statistically significant, the group participants with
ATDwere slightly older than those in the control group. Given the age of the participants, it
is likely that there is a degree of heterogeneity in their pubertal status and, in that context,
the age difference between the groups may have had an influence on the results. In our
study setting, assessment of pubertal stage was not considered appropriate, but the lack of
data is a potential weakness and prevents any adjustment for pubertal status. However,
although sex hormones appear to affect BAT activity in rodents [82] via FSH [83], it is not
known whether human BAT expresses FSH receptors in childhood. Additionally, we did
not show anymeaningful relationship between dietary intake immediately preceding imaging,
or recent physical activity levels, and thermogenic measurements. However, this was
not the focus of this study nor was it designed to rigorously investigate these vari-
ables, so caution should be applied before drawing any firm conclusions from the lack of
association here.
We show that BMI and BMI SDS, weight and weight SDS, and age are all negatively
associated with TSCV (resting, maximal, and at all time points). There was a high degree of
intercorrelation between these variables, and the size of our study means that it is not
possible to distinguish between the relative effects of each variable. However, all of these
variables potentially have a common factor in increasing the insulation between the su-
perficial skin and BAT depot, either by a relative abundance of adipose tissue or by simply an
increased size, suggesting this as a mechanism for reduced skin temperature rather than
necessarily reduced BAT activity. Consistent with this assertion, when TSCV is compared
with a sternal reference point, the association between these variables is no longer signif-
icant, emphasizing the suitability of TRel to control for potential confounders. In contrast,
height and height SDS do not correlate with any outcome measure of IR thermography and
are also less likely to be associated with increased insulation between BAT and the skin
surface, further reinforcing the proposedmechanism. Also, note that despite thermal imaging
producing a two-dimensional image, as opposed to the three-dimensional image of PET-CT,
there is a close relationship between each different measure of BAT function [18].
In summary, BAT activation was reduced in girls with a diagnosis of ATD compared with
healthy controls. The unexpected finding of increased relative BAT temperature in subjects
with suboptimal biochemical control now requires confirmation in larger studies.
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